Answer
Crovalimab is not expected to have pharmacokinetic interactions with medicines affecting cytochrome P450 enzymes because IgG clearance pathways differ from those of small molecules, although no dedicated interaction studies have been conducted.
Sources for this answer
- PiaSky 340 mg solution for injection/infusionRoche Products Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 4Document updated
Sources checked